These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38125134)

  • 1. Retracted: Comparison of Efficacy and Safety of Recombinant Human Prourokinase and Alteplase in the Treatment of STEMI and Analysis of Influencing Factors of Efficacy.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9842016. PubMed ID: 38125134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of intracoronary prourokinase during percutaneous coronary intervention in treating ST-segment elevation myocardial infarction patients: a randomized, controlled study.
    Wu Y; Fu X; Feng Q; Gu X; Hao G; Fan W; Jiang Y
    BMC Cardiovasc Disord; 2020 Jun; 20(1):308. PubMed ID: 32590944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Recombinant Human Prourokinase in the Treatment of Acute Ischemic Stroke Within 4.5 Hours of Stroke Onset: A Phase 3 Randomized Clinical Trial.
    Song H; Wang Y; Ma Q; Feng W; Liu R; Lv X; Huang L; Li Y; Yang Y; Geng D; Zhu J; Wei Y; Chen H; Zhu R; Zhai Q; Guo J; Liu B; Zhao S; Wang Y;
    JAMA Netw Open; 2023 Jul; 6(7):e2325415. PubMed ID: 37490291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of intracoronary recombinant human prourokinase administration in patients with acute myocardial infarction and ST‑segment elevation: A meta‑analysis of randomized controlled trials.
    Fan G; Wu XG; Jiao WP; Zhang HK; Guo DL
    Exp Ther Med; 2023 Jan; 25(1):40. PubMed ID: 36569445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized study of prourokinase during primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction.
    Geng W; Zhang Q; Liu J; Tian X; Zhen L; Song D; Yang Y; Meng H; Wang Y; Chen J
    J Interv Cardiol; 2018 Apr; 31(2):136-143. PubMed ID: 29171086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of prourokinase injection in patients with ST-elevation myocardial infarction: phase IV clinical trials of the prourokinase phase study.
    Zhao L; Zhao Z; Chen X; Li J; Liu J; Li G;
    Heart Vessels; 2018 May; 33(5):507-512. PubMed ID: 29209778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retracted: Effect of Alteplase Thrombolysis on Coagulation Function and Nerve Function of Patients with Ischemic Stroke.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9761312. PubMed ID: 38125186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy and safety of reperfusion therapy with fibrinolytic agents in patients with ST-segment elevation myocardial infarction: a systematic review and network meta-analysis.
    Jinatongthai P; Kongwatcharapong J; Foo CY; Phrommintikul A; Nathisuwan S; Thakkinstian A; Reid CM; Chaiyakunapruk N
    Lancet; 2017 Aug; 390(10096):747-759. PubMed ID: 28831992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of half-dose recombinant human prourokinase thrombolysis combined with early PCI in 48 patients with ST-segment-elevation myocardial infarction (STEMI).
    Gao J; Wang WJ; Liu YH; Luo DL
    Asian J Surg; 2023 Apr; 46(4):1658-1659. PubMed ID: 36210304
    [No Abstract]   [Full Text] [Related]  

  • 10. Retracted: Research on Influencing Factors of Clinical Efficacy of Meniscus Resection Based on Logistic Regression Analysis.
    Scanning
    Scanning; 2023; 2023():9817461. PubMed ID: 37388998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of tenecteplase versus alteplase in STEMI patients treated with ticagrelor: A cross-sectional study.
    Günlü S; Demir M
    Am J Emerg Med; 2022 Aug; 58():52-56. PubMed ID: 35636043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retracted: Comparison of Clinical Efficacy and Safety between Misoprostol and Oxytocin in the Prevention of Postpartum Hemorrhage: A Meta-Analysis.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9895282. PubMed ID: 37829399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
    Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
    Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retracted: Comparison of Efficacy and Safety of TACE Combined with Microwave Ablation and TACE Combined with Cryoablation in the Treatment of Large Hepatocellular Carcinoma.
    Intelligence And Neuroscience C
    Comput Intell Neurosci; 2023; 2023():9837201. PubMed ID: 38074396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retracted: Analysis of Factors Influencing Safety Attitudes of Operating Room Nurses and Their Cognition and Attitudes toward Adverse Event Reporting.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9803936. PubMed ID: 37564814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human TNK tissue-type plasminogen activator (rhTNK-tPA) versus alteplase (rt-PA) as fibrinolytic therapy for acute ST-segment elevation myocardial infarction (China TNK STEMI): protocol for a randomised, controlled, non-inferiority trial.
    Wang HB; Ji P; Zhao XS; Xu H; Yan XY; Yang Q; Yao C; Gao RL; Wu YF; Qiao SB
    BMJ Open; 2017 Sep; 7(9):e016838. PubMed ID: 28928186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retracted: The Significance of Apolipoprotein-A in the Long-Term Death of Patients with STEMI.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9754853. PubMed ID: 37886323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retracted: The Clinical Efficacy and Economic Benefits of Recombinant Human Thrombopoietin for the Treatment of Chemotherapy or Chemoradiotherapy-Induced Thrombocytopenia.
    Imaging CMM
    Contrast Media Mol Imaging; 2023; 2023():9783232. PubMed ID: 37502537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retracted: Influencing Factors of Physical Activity in Patients with Lung Cancer Surgery and Its Correlation with Exercise Self-Efficacy and Perceived Social Support.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9787301. PubMed ID: 37501826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of intracoronary prourokinase administration in patients with high thrombus burden.
    Wang X; Liu H; Wu H; Xiao Y; Bai S; Li X; Li X; Zhang L; Chen T; Li H; Liu J; Du R
    Coron Artery Dis; 2020 Sep; 31(6):493-499. PubMed ID: 32073417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.